Active Ingredient History
Heparin, also known as unfractionated heparin (UFH), is a medication and naturally occurring glycosaminoglycan. Since heparins depend on the activity of antithrombin, they are considered anticoagulants. Specifically it is also used in the treatment of heart attacks and unstable angina. It is given intravenously or by injection under the skin. Other uses for its anticoagulant properties include inside blood specimen test tubes and kidney dialysis machines. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Lung Injury (Phase 1/Phase 2)
Anticoagulants (Phase 4)
Aortic Stenosis, Subvalvular (Phase 4)
Bleeding Time (Phase 3)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
Coronavirus Infections (Phase 4)
COVID-19 (Phase 4)
DNA Mismatch Repair (Phase 1/Phase 2)
Extracorporeal Membrane Oxygenation (Phase 4)
Gram-Negative Bacterial Infections (Phase 3)
Hemorrhage (Phase 4)
Heparin (Phase 3)
Hypertrophy, Left Ventricular (Phase 4)
Leukemia, Lymphoid (Phase 4)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 2)
Pneumonia, Viral (Phase 3)
Pulmonary Embolism (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Insufficiency (Phase 2/Phase 3)
Sepsis (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Shock (Phase 2)
Shock, Septic (Phase 2)
Stroke (Phase 4)
Thrombosis (Phase 4)
Traumatology (Phase 4)
Venous Thromboembolism (Phase 4)
Ventricular Dysfunction, Right (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue